NDC 0008-1210 – Pristiq Extended-Release
Desvenlafaxine Succinate 25 mg/1 · Tablet, Extended Release · Oral
Product NDC0008-1210
Product details
- Brand name
- Pristiq Extended-Release
- Generic name
- Desvenlafaxine succinate
- Labeler
- Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.
- Dosage form
- Tablet, Extended Release
- Route
- Oral
- Marketing category
- NDA · NDA021992
- Marketed since
- April 1, 2015
- Listing expires
- December 31, 2027
- Pharmacologic class
- Serotonin and Norepinephrine Reuptake Inhibitor
Active ingredients
- Desvenlafaxine Succinate 25 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0008-1210-30 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0008-1210-30) | Apr 1, 2015 |
Recalls mentioning this NDC
- D-1409-2014 Jul 2, 2014 · Class II
Presence of Foreign Tablets/Capsules: Pfizer is recalling 50 mg Pristiq (desvenlafaxine) extended release tablets because a single Pristiq 100 mg tablet was found in a bottle of 50 mg Pristiq.